{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-027241","form_type":"8-K","ticker":"MBRX","cik":"0001659617","company_name":"Moleculin Biotech, Inc.","filed_at":"2025-08-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.583006+00:00","generated_at":"2026-05-17T11:57:03.085191+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Moleculin shareholders approve 5x authorized share increase and reverse split authority","bullets":["Authorized common shares increased from 100M to 500M (Proposal 8).","Reverse stock split up to 1:20 authorized (Proposal 9); timing not disclosed.","Share issuance for June 23, 2025 warrants (up to 148.7M shares) approved (Proposal 6).","Equity incentive plan shares increased (Proposal 3); say-on-pay approved (Proposal 4).","Supermajority voting amendment failed (Proposal 7); all 6 directors re-elected."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-027241","json":"https://secwatch.observer/filing/0001437749-25-027241.json","markdown":"https://secwatch.observer/filing/0001437749-25-027241.md","text":"https://secwatch.observer/filing/0001437749-25-027241.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925027241/0001437749-25-027241-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925027241/mbrx20250818c_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T11:57:03.085191+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}